+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Genders
Healthy Volunteers
ID07659847

Five-Year Cardiovascular Health Evaluation After Multisystem Inflammatory Syndrome in Children MIS-C Comparing Affected Individuals and Healthy Controls

Led by Medical University of Warsaw · Updated on 2026-06-22

90

Participants Needed

1

Research Sites

21 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Multisystem inflammatory syndrome in children MIS-C is a serious condition linked to SARS-CoV-2 infection that often affects the heart and blood vessels. While many children recover quickly from acute heart problems, the long-term effects on cardiovascular health are not fully known. This study aims to evaluate heart and blood vessel health five years after MIS-C by comparing affected individuals with similar healthy controls using advanced tests and measurements. Participants include two groups those who had MIS-C and healthy children or young adults matched by age, sex, and body mass index. Each participant will undergo a thorough heart and vascular assessment including blood tests for endothelial injury markers, ultrasound of carotid arteries, heart ultrasound echocardiography, arterial stiffness measurements, and exercise testing on a cycle ergometer. The study focuses on measuring central aortic systolic blood pressure as the main outcome. Participants will attend a study visit approximately five years after MIS-C diagnosis where all assessments will be done. Researchers will compare various cardiovascular parameters, such as blood pressure, arterial stiffness, and exercise capacity, between the groups to identify any lasting abnormalities. This cross-sectional study will help improve understanding of long-term cardiovascular health after MIS-C and may guide future monitoring recommendations.

CONDITIONS

Brief Title

Cardiovascular Assessment 5 Years After MIS-C

Who Can Participate

All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • For the MIS-C group: History of MIS-C diagnosed according to World Health Organization (WHO) criteria
  • For all participants: Written informed consent from a parent or legal guardian
  • For participants aged 16 years or older: Assent or consent from the participant
Not Eligible

You will not qualify if you...

  • MIS-C group: Known heart disease, including congenital heart disease
  • MIS-C group: Significant chronic disease affecting growth, development, or daily functioning
  • Control group: Following an elimination diet
  • Control group: Engaged in competitive athletic training
  • Control group: Known heart disease, including congenital heart disease
  • Control group: Significant chronic disease affecting growth, development, or daily functioning

Research Team

W

Weronika Woźniak-Szewczyk, MD

M

Magdalena Okarska-Napierała, MD PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here